0001179110-16-017212.txt : 20160105 0001179110-16-017212.hdr.sgml : 20160105 20160105183211 ACCESSION NUMBER: 0001179110-16-017212 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160101 FILED AS OF DATE: 20160105 DATE AS OF CHANGE: 20160105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morenstein Scott D CENTRAL INDEX KEY: 0001576113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 161324542 MAIL ADDRESS: STREET 1: C/O CAXTON ALTERNATIVE MANAGEMENT LP STREET 2: 1330 SIXTH AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 edgar.xml FORM 4 - X0306 4 2016-01-01 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001576113 Morenstein Scott D C/O CAXTON ALTERNATIVE MANAGEMENT 1330 6TH AVENUE, 20TH FLOOR NEW YORK NY 10019 1 0 0 0 Common Stock 2016-01-01 4 A 0 17857 0 A 17857 D Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 50% of the shares on each of March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date. /s/ Scott D. Morenstein 2016-01-05